YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.
YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.
复制标题
DOI:
10.1016/j.ydbio.2020.12.018
复制
发表时间:
2021-07
影响因子:
2.7
通讯作者:
Vasioukhin V
中科院分区:
文献类型:
--
作者:
Szulzewsky F;Holland EC;Vasioukhin V
YAP1 is a transcriptional co-activator whose activity is controlled by the Hippo signaling pathway. In addition to important functions in normal tissue homeostasis and regeneration, YAP1 has also prominent functions in cancer initiation, aggressiveness, metastasis, and therapy resistance. In this review we are discussing the molecular functions of YAP1 and its roles in cancer, with a focus on the different mechanisms of de-regulation of YAP1 activity in human cancers, including inactivation of upstream Hippo pathway tumor suppressors, regulation by intersecting pathways, miRNAs, and viral oncogenes. We are also discussing new findings on the function and biology of the recently identified family of YAP1 gene fusions, that constitute a new type of activating mutation of YAP1 and that are the likely oncogenic drivers in several subtypes of human cancers. Lastly, we also discuss different strategies of therapeutic inhibition of YAP1 functions.
登录
查看更多内容
影响因子:
16.6
作者:
Cho YS;Zhu J;Li S;Wang B;Han Y;Jiang J
通讯作者:
Jiang J
影响因子:
10.5
作者:
Chen Q;Zhang N;Xie R;Wang W;Cai J;Choi KS;David KK;Huang B;Yabuta N;Nojima H;Anders RA;Pan D
通讯作者:
Pan D
影响因子:
6.2
作者:
Alexander J;LaPlant QC;Pattwell SS;Szulzewsky F;Cimino PJ;Caruso FP;Pugliese P;Chen Z;Chardon F;Hill AJ;Spurrell C;Ahrendsen D;Pietras A;Starita LM;Hambardzumyan D;Iavarone A;Shendure J;Holland EC
通讯作者:
Holland EC
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
5.7
作者:
Basu, Dipanjan;Lettan, Robert;Rebbaa, Abdelhadi
通讯作者:
Rebbaa, Abdelhadi